PB2313: DARATUMUMAB AS A TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA: A PHASE II STUDY WITH SAFETY RUN-IN (THE DART STUDY)

por Tsykunova, G., Holme, P. A., Thi Thyuet Tran, H., Tvedt, T. H. A., Munthe, L., Michel, M., Frederiksen, H., Bussel, J., Kuter, D., Ghanima, W.
Publicado 2022

P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS...

por Kuter, D., Goldschmidt, H., Cella, D., Petrucci, M. T., Moreau, P., Durie, B., Juarez-Garcia, A., Trong, L., Gu, J., Hernandez Rivera, G., Dhanasiri, S., Marshall, T., Wang, J., Lacoin, L., Ramasamy, K., Vij, R.
Publicado 2022

P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396)

por Röth, A., Barcellini, W., D’Sa, S., Miyakawa, Y., Broome, C. M., Michel, M., Kuter, D. J., Jilma, B., Tvedt, T. H. A., Weitz, I. C., Sourdille, T., Wang, J., Vagge, D. S., Kralova, K., Shafer, F., Wardecki, M., Lee, M., Berentsen, S.
Publicado 2022

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

por Glaspy, J, Jadeja, J Singh, Justice, G, Kessler, J, Richards, D, Schwartzberg, L, Rigas, J, Kuter, D, Harmon, D, Prow, D, Demetri, G, Gordon, D, Arseneau, J, Saven, A, Hynes, H, Boccia, R, O'Byrne, J, Colowick, A B
Publicado 2001